Evaluation of selenium effect on antibody titers of seasonal infiuenza vaccination in adults older than 40 years

Evaluation of selenium effect on antibody titers of seasonal infiuenza vaccination in adult older than 40 years in, Imam Reza hospital, Kermanshah

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201010184959N1

Enrollment

116

Registered

2010-11-12

Start date

2010-10-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza. Influenza and pneumonia

Interventions

Intervention 1: An injection of Trivalent influenza vaccine (VAXIGRIP) in deltoid muscle and selenium selinate (200 micro gm/ daily/ for 30 days). Intervention 2: Trivalent influenza vaccine (VAXIGRIP

Prevention

An injection of Trivalent influenza vaccine (VAXIGRIP) in deltoid muscle and selenium selinate (200 micro gm/ daily/ for 30 days)

Trivalent influenza vaccine (VAXIGRIP) will be injected in deltoid muscle and placebo daily/ for 30 days.

Eligibility

Sex/Gender

All

Age

50 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age more than 40 years old, serum antibody less than 1:40, absence of flu-like syndrome

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Immunity for Influenza Viruses. Timepoint: One month after Vaccination. Method of measurement: With Hemaglutination and Inhibition Method.	—

Secondary

Measure	Time frame
Adverse effect of vaccination. Timepoint: One Month. Method of measurement: Observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Sohrab Heidari

Kermanshah University of Medical Sciences

www.heidarisohrab@yahoo.com A-Heidary@kums.ac.ir+98 83 1426 3264

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026